Category: Intellectual Property and Entrepreneurship ⋅ Page 1

Prof. Dennis Crouch and Mizzou Law student present at 2021 BYU symposium

On August 19, Professor Dennis Crouch and Dr. Homayoon Rafatijo (MU Law 3L) jointly presented their manuscript titled “States Can Infringe upon Your Intellectual Property Rights with Impunity in the Era of ‘New Federalism,” at the 2021 BYU Copyright and Trademark Symposium.  The article criticizes the Supreme Court’s 2020 sovereign immunity decision in Allen v. Cooper, looking primarily through a…

BETR Articles and White Papers Publication Announcement

The Business, Entrepreneurship & Tax Law Review (“BETR”) is proud to announce the following student-written articles that were selected for publication in our Spring 2020 issue:   Clayton Alexander Game Over? How Video Game Console Makers are Speeding Toward an Antitrust Violation Christian Hodgson On the Effort to Discover and Eliminate Offshore Tax Abuse Douglas Mann Cleaning Up and Cashing Out: Using Financial…

Professor Crouch comments on Supreme Court ruling

Professor Dennis Crouch commented in a recent article about the U.S. Supreme Court’s ruling that the U.S. Patent and Trademark Office violated the American Rule, “End Of The Road For USPTO’s ‘Radical’ Fight for Atty Fees.” The article mentions Crouch as one of the first court-watchers to call attention to the USPTO’s requests for fees. He says that “The Supreme…

Ninth Annual University of Missouri Patent Law Moot Court Competition

On Friday, November 15, Mizzou Law hosted the Ninth Annual University of Missouri Patent Law Moot Court Competition. Thirteen students wrote briefs and presented oral arguments in a mock-version of a pending infringement lawsuit involving a patented device for 3D modeling of orthodontistry. Overall winner of the competition this year (brief + arguments) was Kevin Johnston who will receive the…

Pan American Journal of Public Health Publishes Letter from Professor Lietzan

The Pan American Journal of Public Health published a letter from Professor Erika Lietzan, in which she responds to an article about Colombia’s pathways for approval of biosimilar biologics. A 2014 presidential decree in Colombia allowed for three pathways to market for biologics, and the earlier article, written by the country’s Minister of Health and Social Protection and his colleagues,…